🇺🇸 FDA
Patent

US 10421804

Anti-Zika virus antibodies and methods of use

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10421804 (Anti-Zika virus antibodies and methods of use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2039/505, A61K2039/507, A61P, A61P17/02